Press releases

Month Year

Email alerts

Dec 11, 2015

Medtronic Announces FDA Approval of Infuse® Bone Graft for Three New Spine Surgery Indications

Approval adds new implants and new surgical approaches to current spine labeling

DUBLIN - December 11, 2015 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of additional spine surgery indications for Infuse® Bone Graft. Upon...
Dec 11, 2015

Medtronic and Samsung Expand Alliance to Develop Connected Health Solutions for Neuromodulation Patients and Healthcare Providers

DUBLIN - December 11, 2015 - Medtronic plc (NYSE:MDT), the global leader in medical technology, and Samsung Electronics America, a global leader in consumer electronics and digital health, today...
Dec 9, 2015

Medtronic Announces FDA Approval for the Only Full-Body MR Conditional Deep Brain Stimulation Systems

Updated Labeling Allows Greater Patient Access to MRI, a Critical Diagnostic Tool

DUBLIN - December 9, 2015 - Medtronic plc (NYSE: MDT) today announced that systems within its Activa® portfolio of Deep Brain Stimulation (DBS) neurostimulators have received FDA approval for...
Dec 8, 2015

University of Washington to Lead U.S. Expansion of Medtronic's HeartRescue Project

The Newly Formed U.S. HeartRescue Consortium Will Bring Proven Resuscitation Practices to More States to Improve Sudden Cardiac Arrest Survival Rates

DUBLIN - December 8, 2015 - Medtronic (NYSE: MDT) today announced that the University of Washington and King County (Seattle) Emergency Medical Services will lead the U.S. expansion of the...
Dec 3, 2015

Medtronic Reports Second Quarter Financial Results

Revenue of $7.1 Billion Grew 6% on a Comparable, Constant Currency Basis; 62% as Reported

DUBLIN - December 3, 2015 - Medtronic plc (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2016, which ended October 30, 2015. Unless otherwise noted, all...

Show per page